{"id":"https://openalex.org/W3000750489","doi":"https://doi.org/10.1080/21645515.2019.1711300","title":"Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single-dose vaccination strategy for adults in Hong Kong","display_name":"Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single-dose vaccination strategy for adults in Hong Kong","publication_year":2020,"publication_date":"2020-01-24","ids":{"openalex":"https://openalex.org/W3000750489","doi":"https://doi.org/10.1080/21645515.2019.1711300","mag":"3000750489","pmid":"https://pubmed.ncbi.nlm.nih.gov/31977268","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7482754"},"language":"en","primary_location":{"id":"doi:10.1080/21645515.2019.1711300","doi":"https://doi.org/10.1080/21645515.2019.1711300","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2019.1711300","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1711300?needAccess=true&role=button","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1711300?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084295236","display_name":"Jessica J. P. Shami","orcid":"https://orcid.org/0000-0002-1084-1829","observed_orcids":["https://orcid.org/0000-0002-1084-1829"]},"institutions":[{"id":"https://openalex.org/I889458895","display_name":"University of Hong Kong","ror":"https://ror.org/02zhqgq86","country_code":"HK","type":"education","lineage":["https://openalex.org/I889458895"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Jessica J. P. Shami","raw_affiliation_strings":["Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China"],"raw_orcid":"https://orcid.org/0000-0002-1084-1829","affiliations":[{"raw_affiliation_string":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China","institution_ids":["https://openalex.org/I889458895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087474204","display_name":"Swathi Pathadka","orcid":"https://orcid.org/0000-0002-1793-1800","observed_orcids":["https://orcid.org/0000-0002-1793-1800"]},"institutions":[{"id":"https://openalex.org/I889458895","display_name":"University of Hong Kong","ror":"https://ror.org/02zhqgq86","country_code":"HK","type":"education","lineage":["https://openalex.org/I889458895"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Swathi Pathadka","raw_affiliation_strings":["Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China","institution_ids":["https://openalex.org/I889458895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025936391","display_name":"Esther W. Chan","orcid":"https://orcid.org/0000-0002-7602-9470","observed_orcids":["https://orcid.org/0000-0002-7602-9470","https://orcid.org/0000-0003-0919-0966"]},"institutions":[{"id":"https://openalex.org/I889458895","display_name":"University of Hong Kong","ror":"https://ror.org/02zhqgq86","country_code":"HK","type":"education","lineage":["https://openalex.org/I889458895"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Esther W. Chan","raw_affiliation_strings":["Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China","institution_ids":["https://openalex.org/I889458895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020536835","display_name":"Jennifer Hui","orcid":"https://orcid.org/0000-0002-2372-8841","observed_orcids":["https://orcid.org/0000-0002-2372-8841"]},"institutions":[{"id":"https://openalex.org/I4405279968","display_name":"Pfizer (Hong Kong)","ror":"https://ror.org/028b8g929","country_code":"HK","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4405279968"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Jennifer Hui","raw_affiliation_strings":["Pfizer Corporation HK Ltd, Hong Kong, China"],"raw_orcid":"https://orcid.org/0000-0002-2372-8841","affiliations":[{"raw_affiliation_string":"Pfizer Corporation HK Ltd, Hong Kong, China","institution_ids":["https://openalex.org/I4405279968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088700843","display_name":"Reiko Sato","orcid":"https://orcid.org/0000-0003-2785-7103","observed_orcids":["https://orcid.org/0000-0003-2785-7103"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reiko Sato","raw_affiliation_strings":["Pfizer Inc., Collegeville, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., Collegeville, PA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053921611","display_name":"Shilpa Patil","orcid":"https://orcid.org/0000-0001-6483-5160","observed_orcids":["https://orcid.org/0000-0001-6483-5160"]},"institutions":[{"id":"https://openalex.org/I4405279968","display_name":"Pfizer (Hong Kong)","ror":"https://ror.org/028b8g929","country_code":"HK","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4405279968"]}],"countries":["HK"],"is_corresponding":false,"raw_author_name":"Shilpa Patil","raw_affiliation_strings":["Pfizer Inc, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Hong Kong, China","institution_ids":["https://openalex.org/I4405279968"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100372278","display_name":"Xue Li","orcid":"https://orcid.org/0000-0003-4836-7808","observed_orcids":["https://orcid.org/0000-0003-4836-7808","https://orcid.org/0009-0006-9659-5054","https://orcid.org/0000-0001-9329-0905","https://orcid.org/0000-0003-4739-8442","https://orcid.org/0009-0003-6442-5622","https://orcid.org/0009-0006-6977-0419"]},"institutions":[{"id":"https://openalex.org/I889458895","display_name":"University of Hong Kong","ror":"https://ror.org/02zhqgq86","country_code":"HK","type":"education","lineage":["https://openalex.org/I889458895"]}],"countries":["HK"],"is_corresponding":true,"raw_author_name":"Xue Li","raw_affiliation_strings":["Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, Hong Kong, China","institution_ids":["https://openalex.org/I889458895"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100372278"],"corresponding_institution_ids":["https://openalex.org/I889458895"],"apc_list":{"value":2895,"currency":"EUR","value_usd":3175},"apc_paid":null,"fwci":0.8779,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.70556778,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"16","issue":"8","first_page":"1937","last_page":"1944"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.9628999829292297,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.03480000048875809,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pneumococcal-vaccination","display_name":"pneumococcal vaccination","score":0.9259999990463257},{"id":"https://openalex.org/keywords/sequential-immunization","display_name":"sequential vaccination","score":0.781000018119812},{"id":"https://openalex.org/keywords/23-valent-pneumococcal-polysaccharide-vaccine","display_name":"23-valent pneumococcal polysaccharide vaccine","score":0.9020000100135803},{"id":"https://openalex.org/keywords/13-valent-pneumococcal-conjugate-vaccine","display_name":"13-valent pneumococcal conjugate vaccine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pneumococcal-disease","display_name":"pneumococcal infection","score":0.9459999799728394},{"id":"https://openalex.org/keywords/adults","display_name":"adults","score":0.5490000247955322},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.9129999876022339},{"id":"https://openalex.org/keywords/chronic-disease","display_name":"chronic disease","score":0.8859999775886536},{"id":"https://openalex.org/keywords/hong-kong","display_name":"Hong Kong","score":0.6990000009536743},{"id":"https://openalex.org/keywords/vaccination-policy","display_name":"vaccination policy","score":0.3190000057220459},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8112397193908691},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.7996925115585327},{"id":"https://openalex.org/C2778866548","wikidata":"https://www.wikidata.org/wiki/Q7205991","display_name":"Pneumococcal conjugate vaccine","level":4,"score":0.7342848181724548},{"id":"https://openalex.org/C2779664119","wikidata":"https://www.wikidata.org/wiki/Q2100023","display_name":"Pneumococcal polysaccharide vaccine","level":5,"score":0.6706579923629761},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4842810034751892},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.46063506603240967},{"id":"https://openalex.org/C127598652","wikidata":"https://www.wikidata.org/wiki/Q558635","display_name":"Per capita","level":3,"score":0.4442904591560364},{"id":"https://openalex.org/C187316915","wikidata":"https://www.wikidata.org/wiki/Q92307203","display_name":"Case fatality rate","level":3,"score":0.4379357099533081},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33282309770584106},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.22760125994682312},{"id":"https://openalex.org/C3020803494","wikidata":"https://www.wikidata.org/wiki/Q2712836","display_name":"Pneumococcal disease","level":4,"score":0.18062731623649597},{"id":"https://openalex.org/C2781253189","wikidata":"https://www.wikidata.org/wiki/Q221179","display_name":"Streptococcus pneumoniae","level":3,"score":0.17572104930877686},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006723","descriptor_name":"Hong Kong","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011008","descriptor_name":"Pneumococcal Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D011008","descriptor_name":"Pneumococcal Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D011018","descriptor_name":"Pneumonia, Pneumococcal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014611","descriptor_name":"Vaccination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018074","descriptor_name":"Vaccines, Conjugate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022242","descriptor_name":"Pneumococcal Vaccines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/21645515.2019.1711300","doi":"https://doi.org/10.1080/21645515.2019.1711300","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2019.1711300","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1711300?needAccess=true&role=button","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},{"id":"pmid:31977268","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31977268","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human vaccines & immunotherapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7482754","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7482754/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hum Vaccin Immunother","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:08e723bc386a4b528c1faba3a2087036","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/08e723bc386a4b528c1faba3a2087036","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Human Vaccines & Immunotherapeutics, Vol 16, Iss 8, Pp 1937-1944 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/21645515.2019.1711300","doi":"https://doi.org/10.1080/21645515.2019.1711300","is_oa":true,"landing_page_url":"https://doi.org/10.1080/21645515.2019.1711300","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1711300?needAccess=true&role=button","source":{"id":"https://openalex.org/S2483136528","display_name":"Human Vaccines & Immunotherapeutics","issn_l":"2164-5515","issn":["2164-5515","2164-554X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Vaccines & Immunotherapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2919967679","display_name":null,"funder_award_id":"170161","funder_id":"https://openalex.org/F4320318131","funder_display_name":"Pfizer Hong Kong"},{"id":"https://openalex.org/G519192379","display_name":null,"funder_award_id":"170161","funder_id":"https://openalex.org/F4320307765","funder_display_name":"Pfizer"}],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320318131","display_name":"Pfizer Hong Kong","ror":"https://ror.org/028b8g929"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3000750489.pdf","grobid_xml":"https://content.openalex.org/works/W3000750489.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1105814096","https://openalex.org/W1866145098","https://openalex.org/W1963669231","https://openalex.org/W1996665275","https://openalex.org/W1998054438","https://openalex.org/W2000714505","https://openalex.org/W2014964287","https://openalex.org/W2025651568","https://openalex.org/W2028959386","https://openalex.org/W2058585430","https://openalex.org/W2069099392","https://openalex.org/W2076120448","https://openalex.org/W2092545077","https://openalex.org/W2098639662","https://openalex.org/W2102997692","https://openalex.org/W2108602468","https://openalex.org/W2142324382","https://openalex.org/W2143389478","https://openalex.org/W2174465621","https://openalex.org/W2292217379","https://openalex.org/W2342228817","https://openalex.org/W2519603001","https://openalex.org/W2586949160","https://openalex.org/W2609514493","https://openalex.org/W2612030172","https://openalex.org/W2791264171","https://openalex.org/W2803929185","https://openalex.org/W2912278664","https://openalex.org/W3185456633"],"related_works":["https://openalex.org/W3028000637","https://openalex.org/W2953723766","https://openalex.org/W3040036908","https://openalex.org/W4311276459","https://openalex.org/W2897726427","https://openalex.org/W2612030172","https://openalex.org/W2809745565","https://openalex.org/W2804425048","https://openalex.org/W2909025238","https://openalex.org/W4390125682"],"abstract_inverted_index":{"Two":[0],"vaccines,":[1],"23-valent":[2],"pneumococcal":[3,9,20,31,65,225],"polysaccharide":[4],"vaccine":[5,11,32],"(PPSV23)":[6],"and":[7,75,82,120],"13-valent":[8],"conjugate":[10],"(PCV13),":[12],"are":[13,34],"widely":[14],"available":[15],"for":[16,64,188,202],"the":[17,36,45,96,194,197,211,223],"prevention":[18],"of":[19,47,51,61,98,181,213],"disease":[21,66,118,226],"in":[22,35,68,135,137,162,228],"adults.":[23],"However,":[24],"it":[25],"is":[26],"unclear":[27],"how":[28],"cost-effective":[29],"these":[30],"choices":[33],"Hong":[37,69,127,229],"Kong":[38,70],"healthcare":[39],"environment.":[40],"We":[41],"aimed":[42],"to":[43,57,94,221],"assess":[44],"cost-effectiveness":[46,144,212],"a":[48,58,103,126,214,219],"sequential":[49,90,179,215],"administration":[50],"PCV13":[52,182],"followed":[53,183],"by":[54,184],"PPSV23":[55,62,185],"compared":[56],"single":[59],"dose":[60],"vaccination":[63,100,116,180,207,216],"control":[67],"adults":[71,189],"aged":[72,77,190],"\u226565":[73],"years":[74,79],"individuals":[76],"20-64":[78],"with":[80,141,176],"immunocompromising":[81],"chronic":[83],"conditions.":[84],"A":[85],"previously":[86],"developed":[87],"deterministic":[88,195],"cohort":[89],"model":[91,107],"was":[92,123,186],"applied":[93],"compare":[95],"outcomes":[97],"two":[99],"strategies":[101,140],"from":[102,125],"societal":[104],"perspective.":[105],"Population-specific":[106],"input,":[108],"including":[109],"incidence,":[110],"mortality,":[111],"case-fatality,":[112],"risk":[113],"group":[114],"distribution,":[115],"costs,":[117],"management,":[119],"productivity":[121],"loss,":[122],"estimated":[124],"Kong-wide":[128],"electronic":[129],"medical":[130],"database.":[131],"Costs":[132],"were":[133,164,173,200],"valued":[134],"US$":[136],"2017.":[138],"Vaccination":[139],"an":[142],"incremental":[143,149],"ratio":[145],"(ICER,":[146],"defined":[147,165],"as":[148,166,218],"cost":[150],"per":[151,159],"QALY":[152],"saved)":[153],"less":[154],"than":[155],"one":[156],"local":[157],"GDP":[158],"capita":[160],"($46,193":[161],"2017)":[163],"highly":[167],"cost-effective.":[168],"Deterministic":[169],"sensitivity":[170],"analyses":[171],"(SA)":[172],"conducted.":[174],"Compared":[175],"single-dose":[177],"PPSV23,":[178],"cost-saving":[187],"\u226520":[191],"years.":[192],"In":[193],"SA,":[196],"base-case":[198],"results":[199],"robust":[201],"tested":[203],"parameter":[204],"uncertainties.":[205],"Future":[206],"policies":[208],"should":[209],"consider":[210],"strategy":[217],"measure":[220],"reduce":[222],"vaccine-preventable":[224],"burden":[227],"Kong.":[230]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-01-30T00:00:00"}